| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Harpoon Therapeutics, Inc. | Chief Scientific Officer | Employee Stock Option (right to buy) | 135,000 | 28 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122005894-wesche-holger-2022-01-28 | Harpoon Therapeutics, Inc. | 28 Jan 2022 | 1 | $0 | 4 | Chief Scientific Officer | 01 Feb 2022, 15:09 |
| /report/000120919121064443-wesche-holger-2021-11-11 | Harpoon Therapeutics, Inc. | 11 Nov 2021 | 1 | $0 | 4 | Chief Scientific Officer | 15 Nov 2021, 15:04 |
| /report/000120919121045618-wesche-holger-2021-07-01 | Harpoon Therapeutics, Inc. | 01 Jul 2021 | 3 | -$134,000 | 4 | Chief Scientific Officer | 06 Jul 2021, 18:01 |